FNCH
Finch Therapeutics Group Inc
$5.04
Earnings Summary
Revenue | $0Mn |
Net Profits | $-6.95Mn |
Net Profit Margins | -Inf% |
Highlights
Finch Therapeutics Group Inc’s revenue fell -100% since last year same period to $0Mn in the Q2 2023. On a quarterly growth basis, Finch Therapeutics Group Inc has generated -100% fall in its revenue since last 3-months.
Finch Therapeutics Group Inc’s net profit jumped 69.38% since last year same period to $-6.95Mn in the Q2 2023. On a quarterly growth basis, Finch Therapeutics Group Inc has generated 89.13% jump in its net profits since last 3-months.
Finch Therapeutics Group Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q2 2023. On a quarterly growth basis, Finch Therapeutics Group Inc has generated -Inf% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Finch Therapeutics Group Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.03 |
EPS Estimate Current Year | -0.03 |
Highlights
Finch Therapeutics Group Inc’s earning per share (EPS) estimates for the current quarter stand at -0.03 - a -Inf% fall from last quarter’s estimates.
Finch Therapeutics Group Inc’s earning per share (EPS) estimates for the current year stand at -0.03.
Key Ratios
Key ratios of the Finch Therapeutics Group Inc post its Q2 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Finch Therapeutics Group Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the Finch Therapeutics Group Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-10 | -0.03 | 0 | 100% |
₹0 US Stocks a/c Opening Fee